Induction Lorlatinib in Stage III Non-small Cell Lung Cancer
Induction Lorlatinib in Stage III Non-small Cell Lung Cancer
Active, not recruiting · NCT05740943 · Registry updated 2026-01-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Induction Lorlatinib in Stage III Non-small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-01-20 | NCT05740943 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guangdong Provincial People's Hospital | Guangzhou | China | 85 |
| Guangzhou Twelfth People's Hospital | Guangzhou | China | 1 |
| Peking Union Medical College Hospital | Beijin | China | 1 |
| The Second Xiangya Hospital of Central South University | Changsha | China | 67 |